The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
balanced salt solution · SODIUM CHLORIDE 6.4 mg/mL; POTASSIUM CHLORIDE .75 mg/mL; CALCIUM CHLORIDE .48 mg/mL; MAGNESIUM CHLORIDE .3 mg/mL; SODIUM ACETATE 3.9 mg/mL; SODIUM CITRATE 1.7 mg/mL · Solution · Ophthalmic · Alcon Laboratories, Inc.
NDC 00065-0795-15 · 15 mL in 1 BOTTLE · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alcon Laboratories, Inc. | SODIUM CHLORIDE 6.4 mg/mL; POTASSIUM CHLORIDE .75 mg/mL; CALCIUM CHLORIDE .48 mg/mL; MAGNESIUM CHLORIDE .3 mg/mL; SODIUM ACETATE 3.9 mg/mL; SODIUM CITRATE 1.7 mg/mL | Aug 26, 2026 | Sep 3, 2026 |
| Alcon Laboratories, Inc. | SODIUM CHLORIDE .48 mg/mL; POTASSIUM CHLORIDE .3 mg/mL; CALCIUM CHLORIDE .75 mg/mL; MAGNESIUM CHLORIDE 3.9 mg/mL; SODIUM ACETATE 6.4 mg/mL; SODIUM CITRATE 1.7 mg/mL | Jul 22, 2026 | Aug 21, 2026 |
| Alcon Laboratories, Inc. | CALCIUM CHLORIDE .48 mg/mL; MAGNESIUM CHLORIDE .3 mg/mL; POTASSIUM CHLORIDE .75 mg/mL; SODIUM ACETATE 3.9 mg/mL; SODIUM CHLORIDE 6.4 mg/mL; SODIUM CITRATE 1.7 mg/mL | Jul 15, 2026 | Jul 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Bss — NDC 00065-0795-15," retrieved September 3, 2026, https://drugdashboards.com/drug/00065079515.
Free to cite with attribution — see how the data is put together.